JPH0341444B2 - - Google Patents

Info

Publication number
JPH0341444B2
JPH0341444B2 JP57204422A JP20442282A JPH0341444B2 JP H0341444 B2 JPH0341444 B2 JP H0341444B2 JP 57204422 A JP57204422 A JP 57204422A JP 20442282 A JP20442282 A JP 20442282A JP H0341444 B2 JPH0341444 B2 JP H0341444B2
Authority
JP
Japan
Prior art keywords
polyvinylpyrrolidone
stabilizer
hydroflumethiazide
crystal growth
highly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57204422A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58183615A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS58183615A publication Critical patent/JPS58183615A/ja
Publication of JPH0341444B2 publication Critical patent/JPH0341444B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP57204422A 1982-04-19 1982-11-19 高度溶解性医薬及びその製造法 Granted JPS58183615A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206646 1982-04-19
FR8206646A FR2525108B1 (fr) 1982-04-19 1982-04-19 Medicaments a haut degre de solubilite et procede pour leur obtention

Publications (2)

Publication Number Publication Date
JPS58183615A JPS58183615A (ja) 1983-10-26
JPH0341444B2 true JPH0341444B2 (en, 2012) 1991-06-24

Family

ID=9273120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57204422A Granted JPS58183615A (ja) 1982-04-19 1982-11-19 高度溶解性医薬及びその製造法

Country Status (18)

Country Link
US (2) US4610875A (en, 2012)
JP (1) JPS58183615A (en, 2012)
AR (1) AR230183A1 (en, 2012)
AT (1) AT389813B (en, 2012)
AU (1) AU555579B2 (en, 2012)
BE (1) BE894942A (en, 2012)
CA (1) CA1225029A (en, 2012)
CH (1) CH655003A5 (en, 2012)
DE (1) DE3241097A1 (en, 2012)
ES (1) ES517444A0 (en, 2012)
FR (1) FR2525108B1 (en, 2012)
GB (1) GB2119784B (en, 2012)
IE (1) IE54084B1 (en, 2012)
IT (1) IT1153099B (en, 2012)
LU (1) LU84468A1 (en, 2012)
NL (1) NL8204461A (en, 2012)
PT (1) PT75867B (en, 2012)
SE (1) SE8206697L (en, 2012)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPS60139688A (ja) * 1983-12-28 1985-07-24 Tokyo Tanabe Co Ltd 無定形ジヒドロピリジン粉末製剤
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
EP0594573A1 (en) * 1989-11-18 1994-05-04 AgrEvo UK Limited Preparation of propenoic acid derivatives
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
JPH0648937A (ja) * 1992-04-07 1994-02-22 Seitai Kagaku Kenkyusho:Kk 経口投与に適する薬剤およびその製造方法
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5994348A (en) 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
WO1997034601A1 (fr) * 1996-03-18 1997-09-25 Eisai Co., Ltd. Compositions medicamenteuses a solubilite amelioree
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
CA2338256C (en) * 1998-07-20 2008-09-23 Smithkline Beecham Corporation Bioenhanced formulations comprising eprosartan in oral solid dosage form
EP1120120A4 (en) * 1998-10-05 2009-04-29 Eisai R&D Man Co Ltd TABLETS DISSOLVING DIRECTLY IN MOUTH
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE60028754T2 (de) * 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
SK12682001A3 (sk) * 1999-12-08 2002-07-02 Pharmacia Corporation, Corporate Patent Department Celecoxib v tuhej forme so zvýšenou biologickou dostupnosťou
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2001095912A1 (en) 2000-06-16 2001-12-20 Mitsubishi Pharma Corporation COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
DE60135674D1 (de) * 2000-10-24 2008-10-16 Ajinomoto Kk Nateglinid enthaltende präparate
AU2002309172A1 (en) * 2001-06-22 2003-01-08 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
ATE486586T1 (de) * 2001-06-22 2010-11-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen, enthaltend adsorbate eines arzneimittels in amorpher form
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
US20050152932A1 (en) * 2003-06-12 2005-07-14 Valery Normand Non-crystalline perfume or flavor delivery system
US20050048112A1 (en) 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
RU2007123436A (ru) * 2004-12-20 2009-01-27 Др. Редди` Лабораторис Лтд. (IN) Фармацевтическая композиция, содержащая аморфные соединения бензимидазола, и способ ее приготовления
JP5284777B2 (ja) * 2005-04-11 2013-09-11 アボット・ラボラトリーズ 難溶性薬剤の改善された溶解プロファイルを有する医薬組成物
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
WO2007086039A1 (en) * 2006-01-27 2007-08-02 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin A method of producing porous microparticles
PT103743B (pt) * 2007-05-16 2013-01-15 Hovione Farmaciencia S A Processo para preparar derivados de 21-disódio fosfato de pregnanos.
US20110250149A1 (en) * 2008-11-04 2011-10-13 Cipla Limited Tiotropium Bromide Having a Low Degree of Crystallinity
PT2654731T (pt) 2010-12-23 2016-11-07 Abbvie Deutschland Formulações sólidas retard à base de dispersões sólidas
EP2714683A4 (en) 2011-05-27 2014-11-05 Hetero Research Foundation RITONAVIR AMORPH CO-PRECIPITATION

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
JPS5163925A (ja) * 1974-11-30 1976-06-02 Kyowa Hakko Kogyo Kk Muteikeikuroramufuenikooruno seizoho
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
JPS55139319A (en) * 1979-04-13 1980-10-31 Furointo Sangyo Kk Activation of drug soluble in alkali and acid
JPS587609B2 (ja) * 1979-06-17 1983-02-10 フロイント産業株式会社 粉体薬剤のコ−テング法
JPS6024768B2 (ja) * 1979-06-16 1985-06-14 フロイント産業株式会社 活性化薬剤の製法
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
JPS5948810B2 (ja) * 1980-03-22 1984-11-29 山之内製薬株式会社 ニカルジピン持続性製剤用組成物
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
JPS5655370A (en) * 1979-10-13 1981-05-15 Kyorin Pharmaceut Co Ltd Amorphous nicomol
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
ATA427282A (de) 1989-07-15
FR2525108A1 (fr) 1983-10-21
ES8505249A1 (es) 1985-05-16
BE894942A (fr) 1983-05-09
US4610875A (en) 1986-09-09
IT8224368A0 (it) 1982-11-23
LU84468A1 (fr) 1983-06-13
PT75867B (fr) 1986-01-21
CA1225029A (en) 1987-08-04
JPS58183615A (ja) 1983-10-26
GB2119784B (en) 1986-04-03
NL8204461A (nl) 1983-11-16
AU555579B2 (en) 1986-10-02
IT8224368A1 (it) 1984-05-23
US4769236A (en) 1988-09-06
DE3241097A1 (de) 1983-10-20
SE8206697L (sv) 1983-10-20
GB2119784A (en) 1983-11-23
AU9043182A (en) 1983-10-27
IE822610L (en) 1983-10-19
IT1153099B (it) 1987-01-14
ES517444A0 (es) 1985-05-16
FR2525108B1 (fr) 1989-05-12
IE54084B1 (en) 1989-06-07
AR230183A1 (es) 1984-03-01
SE8206697D0 (sv) 1982-11-24
PT75867A (fr) 1982-12-01
CH655003A5 (fr) 1986-03-27
AT389813B (de) 1990-02-12
DE3241097C2 (en, 2012) 1989-04-13

Similar Documents

Publication Publication Date Title
JPH0341444B2 (en, 2012)
EP0346006B1 (en) Pharmaceutical compositions containing ibuprofen-cyclodextrin complexes
US5709886A (en) Effervescent microcapsules
EP0818992B1 (en) Procedure for encapsulating nsaids
JP3233638B2 (ja) 凍結乾燥された薬投与形状物の製造方法
US5405617A (en) Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
US4956386A (en) Pharmaceutical compositions and process for their preparation
CN101248036B (zh) 邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物
WO2003095498A1 (fr) Complexe d'agents therapeutiques organiques et de derives de beta-cyclodextrine et son procede de preparation
JPS5837284B2 (ja) セイヤクソセイブツノセイホウ
US4771077A (en) Spray dried acetaminophen
WO2001026691A1 (fr) Compositions medicamenteuses pour administration orale
AU2003235700B2 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids II
CN109988104A (zh) 山奈酚与异烟酰胺共晶物及制备方法和其药物组合物与用途
CN111718258A (zh) 蓓萨罗丁与聚乙烯吡咯烷酮共无定型物及制备方法和其组合物与用途
JPH02149532A (ja) 小麦ふすまからのヘミセルロースを基材とする徐放性組成物
JPH09316006A (ja) 口腔内溶解性固形製剤
KR100394075B1 (ko) 생체이용율이 증진된 경구용 이트라코나졸 제제
WO1993024111A1 (en) Oral decongestant product
JPS58401B2 (ja) ケイコウヨウイヤクヒンソセイブツノ セイホウ
JPS61172831A (ja) 消炎鎮痛性医薬組成物
CN105816431B (zh) 一种氟氯西林钠掩味颗粒及其制备方法
Sartnurak Evaluation of solid dispersed particles for formulation of oral ibuprofen tablets
JPH0129169B2 (en, 2012)
Uchida et al. Gastrointestinal Absorption of Chlorothiazide Enhanced by Commercial Swelling Polymers in Dogs